Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Theophylline for Diaphragmatic Dysfunction in ICU
NCT04269187Phase 1Unknown
- Sponsor
- Assiut University
- Start
- Apr 2020
- Primary completion
- Apr 2022
- Modality
- Small Molecules
01
Overview
Phase 1, randomised, open-label trial of theophylline in Diaphragmatic dysfunction (DD) (2 arms), sponsored by Assiut University. Primary endpoint: Improvement in diaphragmatic thickness and excursion at Day 12. Status: unknown.
02
Drugs
theophylline
03
Conditions
Diaphragmatic dysfunction (DD)
Beyond the preview
Go deeper on NCT04269187.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04269187.